Mysterious interstellar object aiming at Earth 'not natural' as scientists rule out comet theory
NASA detected the object, dubbed 3I/ATLAS, on July 1, sparking a flurry of scientific analysis to determine its origin.
While more than 200 researchers have concluded it is likely a comet, Harvard physicist Avi Loeb has raised doubts in a newly released pre-print paper, pointing to one glaring omission: 3I/ATLAS has no visible tail.
'There were claims of a tail,' Loeb said, 'but since 3I/ATLAS is accelerating and its current size is not much larger than the angular resolution of Earth-based telescopes, it is not easy to avoid fictitious elongation of the image as a result of the object's motion.'
He also questioned the object's unusual lack of gas emissions and its precise, retrograde trajectory, which aligns suspiciously well with the inner solar system.
Loeb has developed what he calls the 'Loeb Scale', a ranking system to evaluate the likelihood that an object is artificial, and gave 3I/ATLAS a six out of ten.
That suggests it is more likely than not to be engineered, though he emphasized that this score may change as more data becomes available.
Among his more provocative theories, Loeb suggested 3I/ATLAS could be an alien mothership releasing small probes to intercept Earth.
'The more likely scenario from an engineering perspective involves a mothership that releases mini-probes which perform a reverse Oberth maneuver to slow down at perihelion and intercept Earth,' Loeb wrote.
This type of maneuver uses the sun's gravitational pull at the object's closest approach to adjust the trajectory efficiently, enabling the probes to reach Earth without large amounts of fuel.
According to Loeb, these hypothetical probes could arrive between November 21 and December 5, 2025, based on 3I/ATLAS's expected position behind the sun in October, an ideal window for a covert approach.
'It may come to save us or destroy us,' he said. 'We'd better be ready for both options and check whether all interstellar objects are rocks.'
Chris Lintott, an astronomer at the University of Oxford, dismissed Loeb's theory as 'nonsense on stilts,' calling it 'an insult to the exciting work going on to understand this object.'
However, Loeb said his analysis remains rooted in observational data.
His latest paper, based on ground-based telescope readings between July 2 and 29, revealed reddening colors in 3I/ATLAS, usually interpreted as surface dust or organic compounds.
He noted that spectroscopic data from this and three previous studies show no signs of atomic or molecular gas in a coma, a feature typically expected in comets.
While the reddening may suggest dust, it could also mean the object simply has a naturally red surface, much like D-type asteroids or other ancient space rocks.
'Continued monitoring around perihelion is necessary to track changes in activity and color,' the study concluded, 'which will provide insights into the evolution of interstellar materials under solar radiation.'
Loeb has authored four scientific papers on 3I/ATLAS and recently proposed using NASA's Juno spacecraft to intercept the object near Jupiter in 2026, calling it a rare opportunity for 'interstellar archaeology.'
He also believes governments should already be forming task forces, including scientists, policymakers and even psychologists, to determine how to respond and how to break the news to the public without triggering panic.
If 3I/ATLAS is more than just a rock, he said, Earth is woefully unprepared.
'The visitor,' he warned, 'is already in our backyard.'
Even if the object turns out to be artificial, Loeb admitted there's little humanity could do.
At nearly 60 miles per second relative to Earth, it's moving far too fast for any of our current rockets to reach.
Loeb has remained adamant that something about 3I/ATLAS does not add up. He said its retrograde orbit, meaning it's moving against the flow of the solar system, is oddly aligned with Earth's path
'If the hypothesis that 3I/ATLAS is a technological artifact proves correct, there are two possible implications: either its intentions are entirely benign, or they are malign, said Loeb.
'In the first case, humanity needs only to wait and welcome this interstellar messenger with open arms. It is the second scenario that causes serious concern.'
He added that because the second possibility has serious consequences, we can use the idea behind Pascal's wager.
'Blaise Pascal argued that it's smarter to believe in God because the possible benefits of believing are much greater than the losses if you're wrong,' Loeb explained.
'Similarly, in our case, it makes sense to warn humanity about the risk from 3I/ATLAS, even if it turns out to be just a theory.
'The cost of not warning could be much worse than the cost of being wrong.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
4 hours ago
- Sky News
The new space race? NASA accelerates plan to put nuclear reactor on the moon
NASA is accelerating plans to put a nuclear reactor on the moon, and they claim it could happen by 2030. In a directive - a written or oral instruction issued by the US government - to NASA staff earlier this month, Sean Duffy, US transport secretary and the new interim administrator of the space agency, said it should be ready to launch a 100 kilowatt nuclear reactor in five years. Plans to get a reactor on the lunar surface are not new. The NASA website states the space agency is working on the Fission Surface Power Project to create a system capable of generating at least 40 kilowatts of power - but that is less than half of what Mr Duffy has now proposed. He also stressed the importance of America's space agency deploying the technology before China and Russia. "To properly advance this critical technology, to be able to support a future lunar economy, high power energy generation on Mars, and to strengthen our national security in space, it is imperative the agency move quickly," the directive, which was first reported on by Politico, states. A nuclear reactor on the moon would be considered a key step towards building a permanent base for humans to live on the lunar surface. But Mr Duffy warned that the first country to deploy a reactor "could potentially declare a keep-out zone" which he said could significantly inhibit NASA's Artemis mission - the lunar exploration programme which aims to land astronauts back on the moon in 2027. When quizzed about the plan on 5 August, he told reporters: "We're in a race to the moon, in a race with China to the moon. And to have a base on the moon, we need energy." Why use a nuclear reactor? Unlike solar power, which is used on the International Space Station, a small nuclear reactor can operate continuously, Dr Sungwoo Lim, a senior lecturer in space applications, exploration and instrumentation at the University of Surrey told Sky News. This is critical for infrastructure on the moon, which spends two weeks in complete darkness as it slowly orbits the Earth. Nuclear reactors therefore diminish the need for sunlight, and can be used to power life support, communications and other critical science instruments, even in darkness. "In practice, this means astronauts could use a reactor to establish sustainable bases and extend exploration to places where solar energy is impractical," Dr Lim adds, including in the moon's permanently shadowed region, where scientists believe ice water exists. Professor Mike Fitzpatrick, an expert in nuclear technology at Coventry University, adds that the proposal of a 100 kilowatt nuclear reactor, is relatively small compared to most that are built on Earth. To put it in real terms, it takes around three kilowatts to power the kettle in your home. But Prof Fitzpatrick says a smaller reactor could pose as "demonstrator technology", something small and compact that makes it easier to transport it to the moon. "Then you can have a whole array of them," he says. So, what's the catch? While scientists agree that nuclear energy seems like the necessary way to make progress on the moon, Prof Fitzpatrick says questions still remain about safety. "Shipping the fuel to the moon is relatively safe, because at that point it is not particularly toxic, it is the highly reactive fission products that become the issue," he says. "What's going to be the strategy for long-term storage and disposal on the moon after these plants have operated for certain periods of time? The sooner those conversations are had, and you have international consensus, the less likely it is you'll get future friction." 0:55 Dr Lim also questioned Mr Duffy's timescale of 2030, saying meeting the target depends heavily on the space agency's budget. NASA's future funding is currently unknown after Donald Trump's 2026 budget request sought a cut of $6bn (£4.5bn) and the termination of dozens of science programs and missions. Over 2,000 agency employees are also set to voluntarily leave NASA in the coming months under the Trump administration's "deferred resignation" programme. Is this the new space race? Last year, Russia's space agency Roscosmos said it was planning to build a lunar nuclear reactor alongside China's National Space Administration by 2035, in order to power the International Lunar Research Station (ILRS). The collaboration was never formally announced by China but the joint plan was included in a presentation by Chinese officials in April this year, which outlined the 2028 Chang'e-8 lunar mission which aims to lay the groundwork for the ILRS. "Duffy explicitly described it as a competition," says Dr Lim, adding that the move towards lunar exploration signals a renewed moon or space race among major parties like China, Russia, India and the US to claim strategic lunar territory and technology. However, Rossana Deplano a professor of international space law at the University of Leicester, says there is a lot of misunderstanding around "keep out" or safety zones, which Mr Duffy's directive mentions. "Safety zones are explicitly recognised in the Artemis Accords," she says. "They are a notification and consultation zone to be declared in advance in order to avoid harmful interference. "They must be temporary in nature and do not establish state jurisdiction, e.g. they cannot be enforced."
The Herald Scotland
4 hours ago
- The Herald Scotland
Review: The London Philharmonic Orchestra at the Usher Hall
The 1995 work is a modern showpiece for symphony orchestra, as performances by the BBC SSO and National Youth Orchestra of Scotland have demonstrated, and it was a fine introduction to all the sections of the London Philharmonic here, especially the ensemble sound of the basses and the clarity of the wind soloists. The rest of the programme was box office gold, Holst's Planet Suite taking up the second half and the large orchestra occupying every square inch of platform in front of the audience-filled choir stalls. Somewhere offstage the National Youth Choir of Scotland made another memorable contribution to the Festival with the final Neptune movement's ethereal wordless chorus, which now seems redolent of a much healthier 20th century fascination with our Solar System. Elsewhere in the work, classical allusions emerge as readily as scientific ones, from the martial opening of Mars through the popular hymnic theme of joy-bringer Jupiter to the magical exchanges of Uranus. All the details of the marvellous orchestration, including a stellar percussion section, two harps and celesta, and rare sounds like that of the bass oboe, were apparent in Gardner's efficient reading, even if it lacked a little in the way of burnished edge. READ MORE: The first half performance of Rachmaninov's Rhapsody on a Theme of Paganini by Italian pianist Beatrice Rana was also much less flashy than it is often played, and none the worse for that. It is a keyboard show-pony's favourite, but Rana was having none of that in a measured, lyrical reading that allowed the orchestra's first oboe and other soloists their place in the spotlight and featured as beautiful an expression of the Andante Cantabile slow variation as one might hope to hear. The wonder of the work is how the 25 variations flow into one another and from soloist to orchestra and back, so having them enumerated and named in supertitles as well as on the thin free printed programme seemed a pointless distraction. And projecting the composer's programme note for Forest in the same way during the first viola's opening solo at the concert's start was just plain rude. To purchase tickets for the festivals, please click here
Telegraph
5 hours ago
- Telegraph
Lithium could help treat Alzheimer's
Lithium could help treat cases of Alzheimer's disease, a Harvard study suggests. People with the neurodegenerative condition have low levels of the metal in their brain which the study revealed, for the first time, is needed for normal brain function. Experiments in mice found that when a novel form of lithium was given to animals with Alzheimer's disease, it reversed the symptoms, even in severe cases. The scientists now hope to further investigate lithium as a potential treatment in humans with clinical trials. 'These findings reveal physiological effects of endogenous lithium in the brain and indicate that disruption of lithium homeostasis may be an early event in the pathogenesis of Alzheimer's disease,' the scientists write in their study. 'Lithium replacement with amyloid-evading salts is a potential approach to the prevention and treatment of Alzheimer's disease.' Lithium's role in the body has long remained a mystery but it has been used as a medication for mental health conditions such as bipolar disorder and schizophrenia for decades. A decade-long study saw Harvard scientists analyse the brains of deceased donors at various stages of Alzheimer's disease, as well as in people with no disease when they died. They found lithium to be the only one of 27 metals to be at lower levels in cases of disease. Experiments in both humans and mice brain samples found that amyloid plaques, the protein which develops in cases of Alzheimer's and causes disease, pulls lithium out of brain cells. In healthy brains, the lithium, which naturally has a positive charge, stays in the cells and helps maintain normal function. But in brains with amyloid, which is naturally negatively charged, the lithium is attracted to the disease-causing plaque and pulled out of the cells. This depletion triggered the brain's immune defence cells to go awry and caused inflammation and an inhibited ability to break down and clear out the toxic amyloid, which suffocates neurons and leads to cognitive decline and Alzheimer's. Scientists have investigated lithium as a possible treatment for Alzheimer's previously but found existing medications in the form of lithium carbonate to be ineffective and also prone to significant side effects. The Harvard team looked for lithium compounds which are not strongly positive in charge that would be impervious to amyloid and therefore more likely to stay in the cells and not be pulled out. The compound lithium orotate was found to be ideal and in mice studies reversed the course of disease, alleviated symptoms and restored memory. This form of lithium was given in small doses to animals to mimic the natural level of the metal and analysis found it 'almost completely prevented' amyloid from settling in the brain. In older mice with severe disease, the treatment 'was highly effective at reducing amyloid deposition and tau accumulation'. It also 'almost completely reversed the memory loss', the scientists write, whereas the existing lithium medicine had no impact. Lithium orotate also improved learning and spatial memory in old mice with severe amyloid. The authors are reluctant to draw conclusions for humans from these rodent experiments but say this new lithium medicine could be a viable route for future drug studies. Current Alzheimer's drugs such as donanemab and lecanemab do not improve a patient's condition but slow down disease progress. However, these come at significant cost as well as the risk of serious side effects such as brain bleeds and swelling. Neither was approved by the National Institute for Health and Care Excellence for use on the NHS despite being deemed effective and safe by the Medicines and Healthcare products Regulatory Agency. Results 'very encouraging' No drug has yet been discovered that can actually improve a patient's condition and reverse the condition of Alzheimer's. 'You have to be careful about extrapolating from mouse models, and you never know until you try it in a controlled human clinical trial,' study author Prof Bruce Yankner, professor of genetics and neurology at Harvard, said. 'But so far the results are very encouraging. What impresses me the most about lithium is the widespread effect it has on the various manifestations of Alzheimer's. I really have not seen anything quite like it in all my years of working on this disease.' The study is published in the study Nature and in an accompanying opinion piece, Prof Ashley Bush from the University of Melbourne, who was not involved in the research, said the work of the Harvard team exposes 'a possible contributor to Alzheimer's disease and a potential non-conventional therapeutic target'. The work could also lead to improvements for how lithium is used in mental health conditions, she believes, especially in older patients. 'Apart from the implications for treating Alzheimer's disease, the data invite a re-evaluation of lithium-salt variants as treatments for older adults with bipolar disorder,' she writes.
